🔎 Trials Near Me

Akèy › Myozit › Illinois › Chicago

Etid klinik pou Myozit nan Chicago, IL

6 etid pou Myozit ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Ap rekriteFaz 2/3
  • Ann & Robert H. Lurie Children's Hospital of Chicago - Accepting Young Adult and Juvenile Patients, Chicago
  • Northwestern Memorial Hospital - Accepting Adult Patients, Chicago
  • The University of Chicago Medical Center - Accepting Adult and Juvenile Patients, Chicago
Laj 6 a 75 · Tout sèks · Mizajou Sep 17, 2026 · NCT06154252

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

Ap rekriteFaz 2
  • University of Chicago, Department of Medicine: Rheumatology, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07103746

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Ap rekriteFaz 1
  • The University of Chicago Medical Center, Chicago
Laj 18 a 74 · Tout sèks · Mizajou Sep 10, 2026 · NCT07085104

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Ap rekriteFaz 1
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago
Laj 18 a 70 · Tout sèks · Mizajou Aug 28, 2026 · NCT06925542

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Ap rekriteFaz 1/2
  • Nkarta Investigational Site, Chicago
Laj 18 a 75 · Tout sèks · Mizajou Aug 7, 2026 · NCT06733935

A Study of AZD0120 in Autoimmune Diseases

Ap rekriteFaz 1
  • Research Site, Chicago
Laj 18 a 75 · Tout sèks · Mizajou Jul 28, 2026 · NCT07295847

Etid Myozit nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.